Lisa A. Marsch named Andrew G. Wallace Professor
May 4, 2016
Northeast Node Principal Investigator and Center for Technology and Behavioral Health Director Lisa A. Marsch, PhD, was recently appointed the Andrew G. Wallace Professorship at Geisel School of Medicine at Dartmouth. Dr. Marsch’s appointment is a reflection on her dedication to the fields of substance use disorder treatment, behavioral health, and technology. We couldn’t be more proud! Congratulations, Dr. Marsch!
Full article
by Susan Green, published April 13 by the Geisel News Center
Lisa Marsch, a professor of psychiatry and director of the Dartmouth Center for Technology and Behavioral Health, has been appointed to the Andrew G. Wallace Professorship at the Geisel School of Medicine.
“Lisa has built a research program that embodies the spirit of academic excellence that defines the Andrew G. Wallace Professorship,” says Geisel Interim Dean Duane Compton. “Her work with technology to monitor and modify behavior is changing the way that health care is delivered and how people can remotely monitor and treat substance abuse disorders.”
“I am honored to receive this endowed chair named after Dr. Wallace in recognition of his legacy at Dartmouth,” says Marsch. “I understand that in addition to his legacy as a former dean of the medical school, he was an amazing cardiovascular researcher.”
Marsch, who was recruited to Geisel in 2011, has been the principal investigator on 26 grants totaling approximately $50 million in funding, largely from the National Institutes of Health. She has led the development, evaluation, and implementation of technology-based therapeutic tools for addiction treatment, HIV prevention, mental health, chronic pain management, substance abuse prevention, smoking cessation, and obesity. Her work in technology and addiction treatment has been particularly pioneering, as she led the development of the most widely tested and evidence-based mobile intervention for addiction treatment.
Marsch directs the Dartmouth Psychiatric Research Center and the Dartmouth-based Northeast Node of the National Drug Abuse Clinical Trials Network. In addition, she leads a national Science of Behavior Change initiative supported by the National Institutes of Health with partners at Dartmouth, Stanford University, Arizona State University, Drexel University, and Massachusetts Institute of Technology.